A trusted partner in bringing new medicines to life. Fast.
Whether you are a niche biotech firm or large pharma company, we provide services spanning the entire molecular life cycle to accelerate your time to market.
Sai Life Sciences
Sai Life Sciences is one of India’s fastest growing Contract Research, Development & Manufacturing Organizations. As a pure-play, full-service CRO-CDMO, we work with over a 200 global innovator pharma and biotech companies to accelerate the discovery, development, and commercialisation of their NCE small molecule programmes.
Over the past two decades, Sai Life Sciences has served a diverse set of programmes, consistently delivering value based on its quality and responsiveness. Today, it has over 2500 employees across its facilities in India, UK, USA and Japan.
News
Sai Life Sciences enters its Silver Jubilee year; surpasses vision of 25 commercial molecules by 2025
Sai Life Sciences entered its Silver Jubilee year with aplomb, surpassing its vision of supporting global innovator partners in bringing 25 new medicines to market by 2025. The company crossed this milestone two years ahead of schedule and is poised to sustain this momentum on the back of a strong portfolio of molecules at various […]
Read more
News
Sai Life Sciences joins Science Based Targets initiative (SBTi), commits to fight climate change with Science
To help combat climate change, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), announced joining Science Based Targets initiative (SBTi), a global body enabling businesses to set ambitious emission reduction targets in line with the latest climate science. Accordingly, it has committed to set near-term company-wide emission reductions in line with […]
Read more
News
Sai Life Sciences reaffirms commitment to Sustainability, charts out SDGs to be achieved by FY27
On the World Environment Day 2023, Sai Life Sciences, a global Contract Research, Development & Manufacturing Organization (CRO-CDMO), announced its renewed Sustainable Development Goals (SDG) charting out the roadmap to achieve specific environmental, social and governance (ESG) targets by the financial year ending March 31, 2027. Making the announcement, Krishna Kanumuri, CEO & Managing Director, […]
Read more
News
Sai Life Sciences opens SSRL, a dedicated research facility for Schrödinger, at its Hyderabad R&D Campus
• Fully equipped labs with 75-member team set-up and made operational in <100 days Sai Life Sciences, one of India’s fastest growing global Contract Research, Development & Manufacturing Organisations (CRO-CDMO), today announced the opening of Sai Schrödinger Research Laboratories (SSRL) at its R&D campus in Hyderabad, India. The facility was inaugurated by Dr. Karen Akinsanya, […]
Read more
News
Sai Life Sciences and NIIT Foundation partner to create livelihood opportunities for underserved communities in Hyderabad
Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRO-CDMO), today announced entering into an agreement with NIIT Foundation, a not-for-profit education society, to implement youth career development programs for underserved communities in Hyderabad, Telangana. As part of the agreement, NIIT Foundation will develop and run multiple courses, and provide […]
Read more
News
Sai Life Sciences sets up GMP Kilo Lab in Alderley Park, Manchester, UK
Sai Life Sciences today announced the setting up of a GMP Kilo Lab at its facility in Alderley Park, Manchester, UK. The new GMP Kilo Lab will enable Sai Life Sciences to offer drug substance and intermediates supplies ranging from gram to kilogram quantities to meet customer clinical requirements at an accelerated pace. Making the […]
Read more
News
Sai Life Sciences opens new High-Potency API Manufacturing facility at its Bidar Campus
• Designed and validated to handle high potent molecules less than 1 μg/m3 containment• First commercial production batch has commenced Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRO-CDMO), today announced the opening of a new High-Potency API (HPAPI) manufacturing facility at its cGMP API Manufacturing campus in Bidar, […]
Read more
News
Sai Life Sciences inks strategic agreement to set up Schrödinger’s first dedicated offshore Research Laboratories in India
Sai Life Sciences, one of India’s fastest growing global Contract Research, Development & Manufacturing Organisations (CRO-CDMO), today announced that it has entered a 5-year strategic agreement with Schrödinger, whose physics-based computational platform is transforming the way therapeutics and materials are discovered, to set up the Sai Schrödinger Research Laboratories (SSRL) in Hyderabad, India. Being built […]
Read more
Service
Chemistry, manufacturing and controls
For over two decades, we have consistently delivered on a diverse set of NCE development programs for our customers with a track record of bringing value based on quality, pricing and responsiveness. With a strong team of scientists and process engineers, we are up to any challenge involving complex chemical synthesis from route scouting, process development, scale-up to commercial scale. As a leading small molecule contract manufacturing organisation (CMO) we make high quality APIs and intermediates that serve the highly regulated markets of USA, Europe and Japan. Our world-class manufacturing facilities are equipped with flexible and versatile infrastructure, tailored to fit the smaller volume but more complex chemistry coming out of the development pipelines today. And we are continuously investing in making it better.
Read more
Service
Discovery
Since 2006, Sai Life Sciences has been a trusted small molecule CRO partner helping innovator biotech and pharma companies accelerate their drug discovery journey from HIT to IND using creative chemistry supported by high quality Biology, DMPK, toxicology and cGMP scale-up services.
We are known to be responsive, flexible and cost-effective in delivering solutions tailored to suit the program requirements. As a testimony to our efforts, we have built strong relationships with clients spanning diverse therapeutic areas, averaging 10+ years of collaboration. Our strong and growing scientific team provides a fully-integrated service bringing the collective expertise of various teams together to develop a lead candidate.
Read more
News
Sai Life Sciences releases its Sustainability Report 2022
Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), today announced the release of its Sustainability Report 2022, which has been developed as per the Global Reporting Initiative (GRI) standards. With the theme ‘Organising for Sustainability Success’ the Report describes the company’s efforts in progressively reducing the knowing-doing gap by […]
Read more
News
Stephen Hermitage joins Sai Life Sciences as VP, CMC
Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organisation (CRO-CDMO), today announced the joining of Stephen Hermitage (Steve) as Vice President, CMC. In this role Steve will join the global R&D leadership team at Sai Life Sciences, where he will add further deep scientific, process development and drug development experience to the […]
Read more
Facilities
Our R&D and manufacturing facilities located in US, UK and India are built to global standards and cater to an international set of clients. Several new facilities are planned for the near future and existing ones are expanding with state-of-the-art blocks. Our headquarters are in Hyderabad, right in the middle of India. We pride ourselves in a global reach.
Read more